Priyadharsini Rajendran

Drug repurposing in fibrosis: From molecular networks to antifibrotic therapeutics-A narrative review.

Fibrosis is a common pathological endpoint of chronic diseases affecting multiple organs and remains a major cause of morbidity and mortality worldwide. Despite advances in understanding fibrogenesis, current antifibrotic therapies primarily slow rather than reverse disease progression, underscoring the need for more e...